UroGen Pharma URGN
NASDAQ URGN
$35.15 -0.33 (-0.93%)
At close: Oct 22, 2026 · 4:00 PM EDT

UroGen Pharma (URGN) Non-Current Assets (2016 - 2026)

Updated

UroGen Pharma's Non-Current Assets came in at $17.16 million for Q2 2026, up 44.9% from $11.85 million a year earlier and up 5.8% from the prior quarter.

Analysis

UroGen Pharma (URGN) Non-Current Assets (2016 - 2026) Analysis & Trends

At the end of FY2025, UroGen Pharma's Non-Current Assets was $14.43 million, up 50.7% from FY2024.

  • Non-Current Assets has increased in each of the last four years, with a five-year compound annual growth rate of 17.7% (FY2020 to FY2025).
  • Going back by year, Non-Current Assets was $9.58 million in FY2024 (+4.9%), $9.13 million in FY2023 (+36.0%), $6.71 million in FY2022 (+25.3%) and $5.36 million in FY2021 (-16.1%).
  • The Q2 2026 figure represents the highest quarterly Non-Current Assets since Q2 2020.
  • Year-over-year, Non-Current Assets has increased for seven consecutive quarters, with growth averaging 92.7% over the last eight quarters.
  • The fastest year-over-year change in Non-Current Assets over five years came in Q2 2025 (growth of 311.3%), and the weakest in Q2 2024 (a decline of 79.5%).
  • Business Quant data shows URGN's Non-Current Assets at $16.23 million (Q1 2026), $14.43 million (Q4 2025) and $16.5 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 141.07 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 101.45 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 87.87 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 35.42 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 159.77 Bn
10 UroGen Pharma 1.78 Bn 1.29 Bn 65.88 Mn 17.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.16 Mn
Mar 31, 2026 16.23 Mn
Dec 31, 2025 14.43 Mn
Sep 30, 2025 16.50 Mn
Jun 30, 2025 11.85 Mn
Mar 31, 2025 10.44 Mn
Dec 31, 2024 9.58 Mn
Sep 30, 2024 6.85 Mn
Jun 30, 2024 2.88 Mn
Mar 31, 2024 3.81 Mn
Dec 31, 2023 9.13 Mn
Sep 30, 2023 11.51 Mn
Jun 30, 2023 14.03 Mn
Mar 31, 2023 16.98 Mn
Dec 31, 2022 6.71 Mn
Sep 30, 2022 6.88 Mn
Jun 30, 2022 6.52 Mn
Mar 31, 2022 5.19 Mn
Dec 31, 2021 5.36 Mn
Sep 30, 2021 9.46 Mn
API Access

UroGen Pharma Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=URGN&period=max&api_key=YOUR_API_KEY